{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:59:55Z","timestamp":1725605995172},"publisher-location":"Basel","reference-count":29,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034899314"},{"type":"electronic","value":"9783034891608"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/978-3-0348-9160-8_23","type":"book-chapter","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T11:09:35Z","timestamp":1315566575000},"page":"254-264","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulators"],"prefix":"10.1007","author":[{"given":"L.","family":"Schrieber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"23_CR1","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","volume":"8542","author":"DL Scott","year":"1987","unstructured":"Scott DL, Symmons DPM, Coulton BL and Popert AJ. Long term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (i). 8542: 1108\u20131110 (1987).","journal-title":"Lancet (i)."},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1445-5994.1986.tb00030.x","volume":"16","author":"N Manolios","year":"1986","unstructured":"Manolios N and Schrieber L. Current concepts in the etiopathogenesis and treatment of systemic lupus erythematosus (SLE). Aust NZ J Med. 16: 729\u2013743 (1986).","journal-title":"Aust NZ J Med."},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0090-1229(84)90195-8","volume":"31","author":"N Miyaska","year":"1984","unstructured":"Miyaska N, Nakamusa T, Russell IJ, Talal N. Interleukin-2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 31: 109\u2013117 (1984).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"23_CR4","unstructured":"Biologically Based Immunomodulators In the Therapy of Rheumatic Diseases (Ed. Pincus SH, Pisetsky DS and Rosenwasser LJ). Elsevier Science Publishing Co., Inc., Amsterdam, 1986."},{"key":"23_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/clinids\/6.1.51","volume":"6","author":"CA Dinarello","year":"1984","unstructured":"Dinarello CA. Interleukin-1. Rev. Infect. Dis. 6: 51\u201395 (1984).","journal-title":"Rev. Infect. Dis."},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.4049\/jimmunol.138.12.4236","volume":"138","author":"JS Kenney","year":"1987","unstructured":"Kenney JS, Masada MP, Eugui EM, Lustro BM, Mulkins MA and Allison AC. Monoclonal antibodies to human recombinant interleukin 1 (IL 1): Quantitation of IL 1\u03b2 and inhibition of biological activity. J. Immunol. 138: 4236\u20134242 (1987).","journal-title":"J. Immunol."},{"key":"23_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0167-5699(82)80027-3","volume":"3","author":"J Oppenheim","year":"1982","unstructured":"Oppenheim J and Gery I. Interleukin-1 is more than an interleukin. Immunol. Today. 3: 113\u2013119 (1982).","journal-title":"Immunol. Today."},{"key":"23_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/art.1780260806","volume":"26","author":"DD Wood","year":"1983","unstructured":"Wood DD, Ihrie EJ, Dinarello CA and Cohen PL. Isolation of an interleukin-1 like factor from human joint effusions. Arthritis Rheum. 26: 975\u2013983 (1983).","journal-title":"Arthritis Rheum."},{"key":"23_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-065X.1980.tb00327.x","volume":"51","author":"KA Smith","year":"1980","unstructured":"Smith KA. T-cell growth Factor. Immunol. Rev. 51: 337\u2013357 (1980).","journal-title":"Immunol. Rev."},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","volume":"130","author":"M Linker-Israeli","year":"1983","unstructured":"Linker-Israeli M, Bakke A, Kitridou R, Gendler S, Gillis S, Horwitz D. Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus. J. Immunol. 130: 2651\u20132655 (1983).","journal-title":"J. Immunol."},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1172\/JCI110579","volume":"69","author":"J Alocer-Vesela","year":"1982","unstructured":"Alocer-Vesela J, Alarcon-Segoria D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 69: 1388\u20131392 (1982).","journal-title":"J. Clin. Invest."},{"key":"23_CR12","first-page":"520","volume":"59","author":"B Comber","year":"1985","unstructured":"Comber B, Doper EM, Fischback M, Darnell B, Baron S and Talal N. Interleukin-2 in rheumatoid arthritis: Production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin. Exp. Immunol. 59: 520\u2013528 (1985).","journal-title":"Clin. Exp. Immunol."},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4049\/jimmunol.135.4.2865","volume":"135","author":"M Lotze","year":"1985","unstructured":"Lotze M, Matory Y, Ettinghausen S, Ruyner A, Sharrow, S, Seip C, Custer M and Rosenberg S. In vivo administration of purified human interleukin-2 II Half-life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant interleukin-2. J. Immunol. 135: 2865\u20132875 (1985).","journal-title":"J. Immunol."},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"S Rosenberg","year":"1985","unstructured":"Rosenberg S, Lotze M, Muul S, Leitman S, Chang A, Ettinghausen S, Matory Y, Skibber J, Shiloni E, Vetto J, Seipp C, Simpson C and Reichert C. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Eng. J. Med. 313: 1485\u20131492 (1985).","journal-title":"N. Eng. J. Med."},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0167-5699(85)90080-5","volume":"6","author":"G Trinchieri","year":"1985","unstructured":"Trinchieri G and Perussia B. Immune interferon: A pleiotropic lymphokine with multiple effects. Immunology Today. 6: 131\u2013136 (1985).","journal-title":"Immunology Today."},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/art.1780280212","volume":"28","author":"G Husby","year":"1985","unstructured":"Husby G and Williams RC Jr. Immunochemical Studies of interleukin-2 and gamma interferon in rheumatoid arthritis. Arthritis Rheum. 28: 174\u2013181 (1985).","journal-title":"Arthritis Rheum."},{"key":"23_CR17","first-page":"647","volume":"10","author":"TC Cesario","year":"1983","unstructured":"Cesario TC, Andrews BS, Martin DA, Jason M, Treadwell T, Friou G, Tilles JA. Interferon in synovial fluid and serum of patients with rheumatic disease. J. Rheum. 10: 647\u2013650 (1983).","journal-title":"J. Rheum."},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1002\/art.1780300103","volume":"30","author":"GW Cannon","year":"1987","unstructured":"Cannon GW, Schindler JD, Emkey RD, Denes A, Cohen SA, Wolfe F, Saway A, Jaffer AM, Weaver AL and Logers L. Double blind trial of recombinant interferon-gamma versus placebo in rheumatoid arthritis. Arthritis Rheum. 30, S18 (1987).","journal-title":"Arthritis Rheum."},{"key":"23_CR19","first-page":"S115","volume":"30","author":"GS Firestein","year":"1987","unstructured":"Firestein GS, Weissman MH and Zvaifler NJ. Parenteral IFN-\u03b3 in rheumatoid arthritis (RA): effect on disease activity and peripheral blood monocytes (PM). Arthritis Rheum. 30, S115 (1987).","journal-title":"Arthritis Rheum."},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM198508083130601","volume":"313","author":"Ortho Multicenter Transplant Study Group","year":"1985","unstructured":"Ortho Multicenter Transplant Study Group. A randomised clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N. Eng. J. Med. 313: 337\u2013342 (1985).","journal-title":"N. Eng. J. Med."},{"key":"23_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1084\/jem.161.2.378","volume":"161","author":"D Wofsky","year":"1985","unstructured":"Wofsky D and Seaman WE. Successful treatment of autoimmunity in NZB\/NZW F mice with monoclonal antibody to L3T4. J. Exp. Med. 161: 378\u2013381 (1985).","journal-title":"J. Exp. Med."},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4049\/jimmunol.135.3.1698","volume":"135","author":"D Wofsky","year":"1985","unstructured":"Wofsky D, Mayes DC, Woodcock J and Seaman WE. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. J. Immunol. 135: 1698\u20131701 (1985).","journal-title":"J. Immunol."},{"key":"23_CR23","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1084\/jem.154.5.1694","volume":"154","author":"JT Rosenbaum","year":"1981","unstructured":"Rosenbaum JT, Adelman NE, McDevitt HO. In vivo effects of antibodies to immune response gene products. I. Haplotype specific suppression of humoral immune response with a monoclonal anti-I-A. J. Exp. Med. 154: 1694\u20131702 (1981).","journal-title":"J. Exp. Med."},{"key":"23_CR24","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1084\/jem.158.4.1350","volume":"158","author":"NE Adelman","year":"1983","unstructured":"Adelman NE, Watling DL, McDevitt HO. Treatment of (NZBxNZW) F1 disease with anti-I-A monoclonal antibodies. J. Exp. Med. 158: 1350\u20131355 (1983).","journal-title":"J. Exp. Med."},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.134.4.2366","volume":"134","author":"A Huse","year":"1985","unstructured":"Huse A, Wooley PH, Luthra HS, Stuart TM, David CS. Type II collagen-induced arthritis in mice 3. Suppression of arthritis using monoclonal and polyclonal anti-Ia antisera. J. Immunol. 134: 2366\u20132374 (1985).","journal-title":"J. Immunol."},{"key":"23_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/0002-9343(85)90213-X","volume":"78","author":"B Combe","year":"1985","unstructured":"Combe B, Coss B, Clot J, Bonneau M and Sany J. Human placenta-related gammaglobulins in immunomodulating treatment of rheumatoid arthritis. Amer. J. Med. 78: 920\u2013928 (1985).","journal-title":"Amer. J. Med."},{"key":"23_CR27","first-page":"373","volume":"125C","author":"NK Jerne","year":"1974","unstructured":"Jerne NK. Towards a network theory of the immune system. Ann. Immunol. (Paris). 125C: 373\u2013389 (1974).","journal-title":"Ann. Immunol. (Paris).."},{"key":"23_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1172\/JCI110158","volume":"67","author":"NI Abdou","year":"1981","unstructured":"Abdou NI, Hall H, Lindsley HB, Halsey JF and Suzuki T. Network theory in autoimmunity: in vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in SLE. J. Clin. Invest. 67: 1297\u20131304 (1981).","journal-title":"J. Clin. Invest."},{"key":"23_CR29","first-page":"189","volume":"132","author":"BH Hahn","year":"1984","unstructured":"Hahn BH and Ebling FM. Suppression of murine lupus nephritis by administration of anti-idiotypic antibody to DNA. J. Immunol. 132: 189\u2013190 (1984).","journal-title":"J. Immunol."}],"container-title":["Basis for Variability of Response to Anti-Rheumatic Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-9160-8_23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T09:50:13Z","timestamp":1686304213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-0348-9160-8_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"ISBN":["9783034899314","9783034891608"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-9160-8_23","relation":{},"subject":[],"published":{"date-parts":[[1988]]}}}